天域生物回复股票交易异常波动问询：除定增外无重大事项筹划

Summary of Key Points Core Viewpoint - Tianyu Biotechnology Co., Ltd.'s controlling shareholder and actual controller, Luo Weiguo, responded to the inquiry regarding the company's stock trading anomalies, confirming no major asset restructuring or significant transactions are being planned at this time [1]. Group 1: Company Response - As of now, aside from the publicly disclosed issuance of shares to specific targets, there are no ongoing plans for major asset restructuring, share issuance, significant transactions, business restructuring, share buybacks, equity incentives, bankruptcy reorganization, major business cooperation, or the introduction of strategic investors by the controlling shareholder and actual controller [1]. - During the period of abnormal stock trading, the controlling shareholder and actual controller did not engage in buying or selling the company's stock [1].